Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-L-carnitine for Leber hereditary optic neuropathy
2009-016982-26Phase 2Completed
- Sponsor
- Leadiant Biosciences
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of acetyl-l-carnitine in Leber hereditary optic neuropathy (LHON), sponsored by Leadiant Biosciences. Primary endpoints: Visual evoked potential P100 implicit time and Retinocortical time. Started Feb 2011; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
Leber hereditary optic neuropathy (LHON)
Beyond the preview
Go deeper on 2009-016982-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016982-26.